One such innovation is now being trialled in Spain by Corteva, a global agricultural technology company. Corteva’s ...

Instead of requiring personalized gene edits for each patient, the new approach could create a standardized method to use for ...

Gene editing is a group of technologies that enable scientists to precisely alter an organism's DNA. These technologies allow for the addition, removal, or alteration of genetic material at specific ...

Regeneron is adding its name to Tessera Therapeutics’ unique in vivo gene writing program, inking a deal that lets it in on a ...

The gene editing tool known as CRISPR-Cas9 is changing what's possible for treating a wide range of diseases caused by ...

The big biotech, which has made genetic medicine a focus in recent years, is paying Tessera $150 million for rights to a potential one-and-done treatment for alpha-1 antitrypsin deficiency.

The CRISPR gene editing technique has had a dramatic influence on biomedical research, and has even been applied to a few ...

After releasing two gene-edited rice varieties in May this year, scientists are now focusing on developing GE varieties of ...

The United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA ...

A new gene-editing strategy may one day help many people with rare genetic diseases. In a new study published Wednesday in ...

TSRA-196 is a potential one-time treatment to precisely correct the genetic mutation underlying AATD, with Investigational New Drug filing ...

In this article, we will be taking a look at the 8 gene-editing stocks to buy. Gene editing is an advanced medical technique within gene therapy that involves precisely modifying an individual’s DNA ...